Skip to main content

Infectious Diseases

Infectious Diseases, FDA Approvals
Chikungunya Vaccine Fetches FDA Nod for Persons Aged ≥12 Years
Read More
Meeting Highlights, Infectious Diseases
CDC Updates: Immunization Schedules for 2025
Read More
FDA Approvals, Infectious Diseases
FDA Approved Abrysvo, First RSV Vaccine for Immunizing Pregnant Women, as Prophylaxis Against RSV Infection in Infants
Read More
Infectious Diseases
Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer
Read More
Lung Cancer, Infectious Diseases, Oncology
Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care
Walter Alexander
Walter Alexander
Read More
Infectious Diseases
COVID-Related Death Rate Tripled in Patients with Cancer versus the General Population
Phoebe Starr
Phoebe Starr
Read More
Perspectives, Infectious Diseases
Are Nursing Homes COVID-19’s “Contaminated Wells,” and Will They Receive Additional Resources?
Bruce S. Pyenson, FSA, MAAA, David C. Grabowski, PhD
Bruce Pyenson, FSA, MAAA, and David C. Grabowski, PhD
Read More
Perspectives, Infectious Diseases
90 Days in 2020: COVID-19 Exposes Health Equity Opportunities
Byron C. Scott, MD, MBA
Byron C. Scott, MD, MBA
Read More
Original Research, Practice Management, Infectious Diseases
Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models
Thomas Lodise, PhD, PharmD, Kenneth LaPensee, PhD, MPH
Thomas Lodise, PhD, PharmD; Kenneth LaPensee, PhD, MPH
Read More

Results 1 - 9 of 9